ALDH3A1 has been demonstrated to trigger EMT in melanoma and non-small cell lung cancer cells, while the overexpression of ALDH3A1 enhances PD-L1 expression and lowers monocyte proliferation in peripheral blood [90]. This evidence concerns the gene ALDH3A1 and melanoma.